Company profile: NeoLight
1.1 - Company Overview
Company description
- Provider of neonatal medical devices and education, including Skylife phototherapy beds with a 3D Light Array for treating newborn jaundice; ICON retinal imaging cameras for ROP screening with Direct Illumination; the portable ICON GO; P.A.L. technology supporting non-nutritive sucking to aid oral feeding progression; and the C.A.R.E.S. continuing medical education program.
Products and services
- ICON: Neolight develops the ICON retinal imaging camera, Direct Illumination-based, producing high-quality imaging for ROP screening in neonatal care with precise visualization of the retina
- ICON GO: Neolight produces ICON GO, a portable version of the ICON system, enabling easy transport and use across various hospital departments for flexible cross-department deployment
- Skylife: Neolight engineers a neonatal phototherapy bed using a 3D Light Array-based system to deliver targeted treatment for newborn jaundice in pre-term and full-term babies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NeoLight
BabyBloom Healthcare
HQ: The Netherlands
Website
- Description: Provider of leading neonatology equipment that creates warm, safe, and comfortable environments for babies worldwide, supporting parents and medical staff; based in the Leiden BioSciencePark in the Netherlands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BabyBloom Healthcare company profile →
Veradermics
HQ: United States
Website
- Description: Provider of dermatology therapies and novel drug delivery mechanisms aimed at pain-free treatment of skin conditions such as warts. Offerings include VDPHL, a non-hormonal once-daily oral treatment for pattern hair loss, and VDMN, an immunostimulatory dissolvable microarray for warts, plus a pipeline targeting androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veradermics company profile →
Viridian Pharma
HQ: United Kingdom
Website
- Description: Provider of niche pharmaceutical products for hospital use, developed and marketed in the UK. Established in 2002 and now part of Martindale Pharma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Viridian Pharma company profile →
Vitara
HQ: United States
Website
- Description: Provider of a therapeutic platform for premature infants that mimics natural physiological processes to improve survival and quality of life; the EXTEND extra-uterine system delivering womb-like support to study development with potential clinical applications; and artificial placenta and womb technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vitara company profile →
Owlet
HQ: United States
Website
- Description: Provider of smart baby monitoring solutions, including the FDA-cleared Dream Sock that tracks infants’ pulse rate and oxygen levels with caregiver notifications; the Owlet Cam for live video and audio monitoring; and BabySat, a prescription pulse oximetry device for real-time monitoring of pulse rate and oxygen saturation under physician supervision.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Owlet company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NeoLight
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NeoLight
2.2 - Growth funds investing in similar companies to NeoLight
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NeoLight
4.2 - Public trading comparable groups for NeoLight
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →